• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Professional Introduction to Compound with CAS No. 117820-89-0 and Product Name: 3-(Dimethylamino)-2-(dimethyliminiomethyl)prop-2-enylidenedimethylammonium ditetrafluoroborate

The compound with the CAS number 117820-89-0 and the product name 3-(Dimethylamino)-2-(dimethyliminiomethyl)prop-2-enylidenedimethylammonium ditetrafluoroborate represents a fascinating molecule in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has garnered significant attention due to its potential applications in various scientific domains. The molecular structure of this compound includes a highly reactive dimethyliminiomethyl group, which is flanked by two dimethylamino substituents, making it a versatile intermediate in organic synthesis and a candidate for further functionalization.

In recent years, the exploration of novel heterocyclic compounds has led to groundbreaking discoveries in medicinal chemistry. The presence of a prop-2-enylidenedimethylammonium core in this molecule suggests its utility in the development of new pharmacophores. This core structure is particularly interesting because it can form stable complexes with various anions, including the ditetrafluoroborate counterion present in this compound. The tetrafluoroborate anion is known for its stability and compatibility with a wide range of organic systems, making it an ideal choice for stabilizing reactive intermediates.

One of the most compelling aspects of this compound is its potential application in the field of drug design. The dimethylamino groups provide a basic nitrogen environment that can interact with acidic functional groups in biological targets, such as enzymes and receptors. This interaction can be modulated to achieve desired pharmacological effects. For instance, compounds with similar structural motifs have been explored as kinase inhibitors, where the ability to bind tightly to the active site of the enzyme is crucial for efficacy.

Recent advancements in computational chemistry have enabled researchers to predict the binding affinities and mechanisms of action of novel compounds with high accuracy. The 3-(Dimethylamino)-2-(dimethyliminiomethyl)prop-2-enylidenedimethylammonium ditetrafluoroborate has been subjected to molecular docking studies to evaluate its potential as an inhibitor of various therapeutic targets. These studies have revealed promising interactions with enzymes involved in cancer metabolism, suggesting its potential as an anticancer agent.

The synthesis of this compound involves multiple steps, each requiring precise control over reaction conditions to ensure high yield and purity. The dimethyliminiomethyl group is particularly challenging to introduce due to its reactivity, but modern synthetic techniques have made it feasible to achieve this transformation efficiently. Researchers have employed catalytic methods that minimize side reactions and maximize the formation of the desired product.

In addition to its pharmaceutical applications, this compound has shown promise in materials science. The unique electronic properties of the prop-2-enylidenedimethylammonium core make it an attractive candidate for developing new types of organic semiconductors and conductive polymers. These materials could find applications in flexible electronics, solar cells, and other advanced technological devices.

The stability provided by the ditetrafluoroborate anion also makes this compound suitable for use in harsh environments where other counterions might decompose or react unfavorably. This stability has been confirmed through various analytical techniques, including nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. These studies have provided detailed insights into the molecular structure and conformational preferences of the compound.

As research continues to evolve, the applications of this compound are likely to expand into new areas. For instance, its potential as a ligand in coordination chemistry has not been fully explored yet. The ability to form stable complexes with transition metals could open up new possibilities for catalytic applications.

The development of novel synthetic methodologies is also crucial for maximizing the utility of this compound. Researchers are exploring green chemistry approaches that reduce waste and energy consumption while maintaining high yields. These efforts align with global initiatives to promote sustainable chemical practices.

In conclusion, the compound with CAS number 117820-89-0 and product name 3-(Dimethylamino)-2-(dimethyliminiomethyl)prop-2-enylidenedimethylammonium ditetrafluoroborate represents a significant advancement in chemical biology and pharmaceutical research. Its unique structural features and versatile reactivity make it a valuable tool for drug discovery, materials science, and beyond. As our understanding of molecular interactions continues to grow, so too will the applications of this remarkable compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)